CW January 2005Issue Number 1 January 2005 ISSN 10593802 A New Nanoparticle Drug Approved for Advanced Breast Cancer PatientsThe US Food and Drug Administration (FDA) has approved an albumin-based nanoparticle formulation of paclitaxel for injection in treating metastatic breast cancer patients. This approval marks a new class of ?protein-bound particle? drugs.
Go to Previous Page Go to Next Page Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW January 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |